The Vanguard High Dividend Yield Index Fund ETF is a moderate-yielding fund that is well-diversified and well-balanced ...

Gedatolisib's phase 3 breast cancer success supports a Buy ahead of potential 2026 FDA approval. Click here to read more.

Maybe just to add to that, OUS as well, we continue to advance or engage new countries that we are going to be launching ...